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Abstract:
The global phenomenon of drug counterfeiting is a threat to both patients and
healthcare systems alike. Counterfeit drugs can build bacterial resistance to antibiotics,
undermine public trust in prescribed medications, fail to alleviate sickness, or even hurt
the patient. Annually, thousands of people die from ingesting fake drugs (Blackstone et
al., 2014). In order to combat the global prevalence of drug counterfeiting, it is important
to test suspect drugs for legitimacy and then report findings back to relevant authorities
that can enforce drug quality standards (Lieberman, 2018).
High performance liquid chromatography (HPLC) is an analytical method that
can determine the legitimacy of drug samples with excellent accuracy (Lieberman, 2018).
Antibiotic drugs, such as amoxicillin, are ubiquitous and commonly prescribed for
bacterial infections. Since these drugs are widely available globally, it can be assumed
that they are commonly counterfeited. This project sought to determine whether selected
samples of Amoxicillin are legitimate or counterfeit through testing with HPLC. Based
on a retention time of around 3 minutes and peak characteristics consistent with
chromatograms from a standard sample of amoxicillin, it was concluded that none of the
supplied suspect samples of amoxicillin were counterfeit.
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Introduction
Counterfeit drugs, including antibiotics, are a threat to public health around the
world, most notably in developing countries. Drug samples were retrieved from West
African drug markets by the University of Notre Dame, and then forwarded to Dr. Corina
Brown for undergraduate student research utilizing HPLC for analysis, along with
reference standard samples. The main guiding question of the research was stated as
follows: Can recent samples of amoxicillin from drug markets in West Africa be
determined to be legitimate or counterfeit with HPLC?

Project Overview
Throughout the project, HPLC was used to analyze samples of Amoxicillin to
determine if they are counterfeit. In order to do this, a methodology for amoxicillin was
used in order to produce an accurate calibration curve. The samples, pulled from West
African markets, were provided by the Notre Dame DPAL (Lieberman, 2018).

The HPLC System
HPLC involves dissolving a specified chemical analyte and pumping it under high
pressures through a column containing an organic stationary phase. The instrument’s
detector then collects the UV absorbance of the analyte and reports the resulting
chromatogram back to the user through a software program. The chromatogram
represents the intensity of UV absorbance versus time of elution from the column. By
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comparing the unknown analyte chromatogram with that of a known analyte, the
researcher can determine whether a sample of drug is legitimate or not (Lieberman,
2018). Within the typical HPLC system, the main components include solvent reservoirs,
pumps, injector, column, detector, and data acquisition and control system (Lieberman,
2018). Different analytes require different analytical methods based on their chemical
properties. These methods determine the type of the HPLC column as well as the solvents
used and their ratios (Lieberman, 2018).

Data Collection Procedures
A computer with specialized software from the HPLC manufacturer acts as the
data acquisition and control system. It controls all parameters of the HPLC instrument,
including temperature, injection sequence, flow rate, and ratio of solvent flow. The
computer acquires data from the detector as well as system performance data, like solvent
pressure, runtime, flow rate, etc. (Kazakevich & Lobrutto, 2007). The Chromatogram
from a run of a Shimadzu HPLC instrument is read out on the Class VP data acquisition
software.

Data Analysis Procedures
When analyzing data from a HPLC chromatogram, one mainly observes the
magnitude of peaks and the retention time at which a peak occurs. For example, one
could observe a large peak at 4 minutes, followed by several peaks that were smaller in
magnitude. The first large peak indicates the drug being released from the column, and
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the smaller peaks could be attributed to degradation products or impurities contaminating
the drug sample. In amoxicillin, the time of elution, where the apex of the peak begins,
occurs a little after 3 minutes (Lieberman, 2018). A proper peak will be narrow and sharp
with a peak area that correlates linearly with concentration.

Statistical Analysis
According to the HPLC methodology manual by Professor Marya Lieberman, a
suitable HPLC instrument would need to show a relative standard deviation of less than
2% after six consecutive injections of a standard (Lieberman, 2018). This level of
precision is necessary to avoid reading false negative or false positive results from a
chromatogram. A sample that is suspected to be counterfeit must be investigated by assay
several times before it can be reported to the WHO and local government authorities
(Lieberman, 2018). The standard curves will be deemed acceptable if they have a
correlation coefficient (r²) of greater than 0.98. The analyzed samples will be compared
with the parameters of the standard sample. A standard deviation value greater than (+/-)
10% would indicate unacceptable variation in the sample results.

Background and Definition
The prevalence of counterfeit drugs is a widespread problem, especially in
developing countries. Although the problem of fake drugs is more serious in the
developing world, developed nations are not invulnerable to counterfeit drug
proliferation: a WHO bulletin stated that less than one percent of drugs may be
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counterfeit in Western Europe and the U.S. (WHO, 2010). People who ingest counterfeit
drugs can see their health condition unchanged or even worsen, sometimes resulting in
death (Kelesidis & Falagas, 2015). According to a directive published by the European
Union, “A counterfeit medicinal product is defined as any medicinal product with a false
representation of:
● Its identity, including its packaging and labeling, its name, or its composition as
regards any of the ingredients including excipients and the strength of those
ingredients.
● Its source, including its manufacturer, its country of manufacturing, its country of
origin or its marketing authorization holder; or its history, including the records
and documents relating to the distribution channels used (European Union News,
2017).”

Research Question
The following research was guided by the question: Can recent samples of
amoxicillin from drug markets in West Africa be determined to be legitimate or
counterfeit? To answer this question, high performance liquid chromatography (HPLC)
was used to analyze the samples based on comparison to a reference standard.

Significance of the Study
According to Dr. Marya Lieberman of the University of Notre Dame, the research
goal is stated: “Through this project, we will work to detect falsified medicines efficiently
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in low-resource settings and track the supply chains through which these bad-quality
products move. By working with partners in the health system and with regulatory
agencies, we hope to protect patients from dangerous fake drugs” (Lieberman, 2018).
This research could potentially save the lives of people who depend on reliable access to
antimicrobial drugs, like amoxicillin. Counterfeit drugs affect millions of people all over
the world, not just in Africa. By testing suspect samples and reporting confirmed
counterfeit drugs to the WHO Rapid Alert system and to the relevant national Medical
Regulatory Authority, we can reduce the prevalence of counterfeits (WHO, 2010).
By informing the proper authorities of incidents of drug counterfeiting, they may gain
more legitimacy and public trust. In unstable, developing countries, trust in governing
institutions can be undermined by corruption and mismanagement (Jarrells, 2015). A
proper response from the government could help to redress the public’s concerns
(Jarrells, 2015).
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Literature Review
Counterfeit Drugs
The counterfeit drug industry is a very lucrative business: It is estimated that,
globally, counterfeit drugs provide around $75 billion in revenue every year to sellers
(WHO, 2010). By replacing the expensive active drug ingredient with something
inexpensive and ineffective such as cassava flour and then charging the market price of
the real drug, sellers can make several magnitudes of profit from unwitting buyers
(Kelesidis & Falagas, 2015). A counterfeit drug vendor in Cameroon can make an
average of $40 USD a day, which is much more than the average $1.25 daily wage. Even
when a vendor is raided by police, they maintain the bulk of their supplies and go on to
sell more (Jarrells, 2015). Prosecution for counterfeit drug crime is infrequent and
extradition is rare, so the risk for sellers is low (Jarrells, 2015). If the legal penalties
incurred cost less than the profits made from selling fake drugs, a seller will still make a
significant profit. What drugs are counterfeited the most often? It seems that the market is
most saturated with beta-lactam antibiotics and anti-malarial drugs like chloroquine: most
of these drugs merely have a reduced concentration of the active drugs, and most can be
traced back to South-East Asia and Africa (Kelesidis & Falagas, 2015).
Counterfeiting is more prevalent in third world or developing countries. In these
places, wages can be as low as $1.25 a day, driving demand for cheaper black-market
goods which are not beholden to first-world quality standards (Jarrells, 2015). According
to the WHO, it is estimated that in certain areas of Africa, Asia, and South America over
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30% of medications on the market are falsified (WHO, 2010). In some Eastern European
countries, the proportion of counterfeits on the market may be over 20% (WHO, 2010).
In Western developed countries such as Germany, less than one percent of medications
consumed can be assumed to be fake (WHO, 2010). However, due to recent events, most
noticeably the COVID-19 pandemic, certain drugs have been claimed to be cure-alls or
counterfeited: the US FDA is looking out for scammers passing off other drugs as
treatments for COVID-19 (FDA, 2020).
Why is the counterfeit drug market so successful in sub-Saharan Africa?
According to an article by Jarrells (2015), this is due to lack of access to quality,
affordable medications, and generally high disease burden (Jarrells, 2015). Low
purchasing power, corruption, and consumer ignorance only compound the problem
(Nakkazi, 2010). Jarrells found that, in the Democratic Republic of the Congo, it took a
full 50% of one family member’s salary for a month to purchase the most affordable
drugs on the market (Jarrells, 2015). Over the whole African continent, it is estimated
that the proportion of counterfeit or substandard drugs accounts for 30% of the
pharmaceutical market (Brower, 2017). A study by Kelesidis et al. (2015) found that, in
developing countries in Africa, 7.6% of major antibiotic formulations contained no active
ingredient whatsoever and 17.8% of antibiotics were substandard.

The Human Cost of Counterfeiting
People who ingest counterfeit medication can become even more ill, often dying
from illness due to poisoning. In the best-case scenario, a patient who takes a counterfeit
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drug will notice no change in their condition; however, in extreme cases, the infection
might develop into septicemia, a life-threatening condition (Delepierre et al., 2012). In
other cases, toxic chemicals or pathogenic contaminants might be inadvertently packaged
with the fake drugs. For example, a patient who took pills contaminated with methanol
might be blinded or even enter a coma (Delepierre et al., 2012). According to a study by
Blackstone et al. (2014), it is estimated that fake drugs kill 100,000 people worldwide
annually.
Many of the drugs sold, even if they are legitimate, may be beyond their
expiration date due to insufficient observation of expiration dates and storage conditions
in improper settings (Vlieghe et al., 2009). A study in Laos found that 0.8% of analyzed
samples had expired at the time of sample collection (Tabernero et al., 2019). In the case
of antimicrobial drugs, it is vitally important that the drugs contain enough of the active
ingredient: as a drug passes its expiration date, the amount of active ingredient within a
sample decreases and drug efficacy suffers (Tabernero et al., 2019). If the active
antibiotic drug concentration is too low, there is a risk that the bacteria causing a patient’s
infection will survive the antibiotic regimen and continue to affect the patient. A
significant chance then arises of accidentally breeding antibiotic-resistant strains of
bacteria from the surviving bacterial strains (Kelesidis & Falagas, 2015). A study by
Vlieghe et al. (2009) discovered “alarming resistance rates in nearly all pathogens”
reviewing the published literature on antimicrobial resistance in Africa since 1955
(Vlieghe et al., 2009). If antimicrobial resistance continues to increase, even legitimate
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antibiotics may become ineffective in fighting common infections (Kelesidis & Falagas,
2015).

Counterfeit Prevention
On the international level, several organizations have formed to try to combat the
prevalence of counterfeit drugs. The WHO created the International Medical Products
Anti-Counterfeiting Taskforce (IMPACT), an organization which mandates the
collaboration of patients, healthcare providers, the healthcare industry, and local
government institutions (Kelesidis & Falagas, 2015). The European Union established the
international organization Medicrime, which prosecutes criminals in the counterfeit drug
industry (Kelesidis & Falagas, 2015).
On the national level, how might a country go about reducing the prevalence of
counterfeit drugs? Strong institutions could be formed, and laws could be enacted and
enforced (Jarrells, 2015). However, this may not be feasible given a certain country’s
political and economic situation. In many developing countries, there are no strong
organizations like the FDA to test and approve drugs for the pharmaceutical market
(Jarrells, 2015). And when laws are passed to prevent the spread of counterfeits,
oftentimes they are ineffectual or unenforceable. An example of this would be laws
designed to protect the intellectual property of pharmaceutical companies: in effect, they
serve to reduce access to legitimate generic drugs while only protecting the profits of
pharmaceutical companies (Jarrells, 2015).
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Public education can be utilized to inform the public and help them to pick out
potential counterfeit drugs. In Cambodia, the government started sensitization campaigns
to encourage patients to only buy drugs in legitimate, authorized pharmacies (Kelesidis &
Falagas, 2015). Information sites on counterfeit drugs have been established in Nigeria,
Thailand, and Cambodia (Kelesidis & Falagas, 2015). These sites warn viewers about the
risks of taking counterfeit drugs and how to avoid mistakenly purchasing them (Kelesidis
& Falagas, 2015). If people have advance knowledge of the threat posed by fake drugs,
they will be more vigilant when searching for medications and possibly avoid the
consequences of taking falsified drugs.

Amoxicillin
Amoxicillin is a semi-synthetic penicillin-derived drug first invented in 1972 at
Beecham Research Laboratories in England (Todd & Benfield, 1990). It is primarily used
to treat bacterial infections in the ears, sinus, skin, lungs, and urinary tract (Rosalyn &
James, 2015). A wide variety of bacteria are susceptible, covering many gram-positive
and some gram-negative strains (Akhavan et al., 2020). Susceptible bacteria include such
species as H. influenzae, E. coli, and Streptococcus pneumoniae (Carson-DeWitt, 2015).
Amoxicillin is often paired with clavulanic acid to boost its antibacterial effect: in
this form it is called Amoxiclav or Augmentin (Todd & Benfield, 1990). Clavulanic acid
is a beta-lactamase inhibitor: it enhances the antibacterial spectrum of amoxicillin by
reducing the ability of beta-lactamase producing bacteria to break down the drug (Todd &
Benfield, 1990). Currently, the samples tested in this lab lack clavulanic acid, but testing
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the two mixed together is totally feasible and requires no modifications to the specific
HPLC method. In that case, there would be a separate clavulanic acid peak along with the
amoxicillin peak in the chromatogram (Atici et al., 2016).

Structure, Uses, Dosage, and Side Effects of Amoxicillin
The chemical name of Amoxicillin is (2S,5R,6R)-6- {[(2R)-2-amino-2-(
4-hydroxyphenyl) -acetyl]
amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (Todd &
Benfield, 1990). Amoxicillin is considered an amino penicillin since it has an additional
amino group added to its structure in order to reduce antimicrobial resistance (Akhavan et
al., 2020). The structure of amoxicillin is presented in Figure 1 (Todd & Benfield, 1990).

Figure 1: Structure of Amoxicillin (Todd & Benfield, 1990)
Dosage, Mechanism of Action, and Side Effects
Amoxicillin is usually administered orally two or three times a day with a
recommended dose of 250-500mg for adults (Carson-DeWitt, 2015). Amoxicillin, as a
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beta-lactam antibiotic, kills bacteria by binding to penicillin-binding proteins that inhibit
the process of transpeptidation in bacterial cell walls. As a result, autolytic enzymes are
activated that lyse the cell wall apart, causing the destruction of the bacteria itself
(Akhavan et al., 2020). Amoxicillin rarely causes adverse effects, but when it does some
report gastrointestinal symptoms such as nausea and vomiting. Some individuals may be
allergic to the drug and have hypersensitivity reactions: there is a small possibility of
anaphylaxis. Infections with resistant microbes are possible, such as fungi or Clostridium
difficile (Akhavan et al., 2020).

23

Methodology

Alternatives to HPLC for Counterfeit Drug Detection
Apart from HPLC, there are some other analytical methods used to distinguish
counterfeit drugs. One of these methods is called DART mass spectrometry; DART
stands for Direct Analysis in Real Time (Chernetsova et al., 2011). A study by
Chernetsova et al. (2011) found that DART mass spectra could successfully be used to
rapidly identify drug ingredients of low molecular weights (Chernetsova et al., 2011).
However, the DART equipment can be hard to acquire and expensive due to its recent
invention and implementation (Chernetsova et al., 2011).
Another method, analyzing the color composition of secondary packaging and
tablet color, was used by Rodomonte et al. (2010) to rapidly identify counterfeits. A
colorimeter and connected computer were used to compare the color of suspect samples
with a reference standard (Rodomonte et al., 2010). The technique was noted to be very
fast, inexpensive, and portable. However, some drawbacks included misidentifying
genuine drugs as counterfeit when the genuine packaging material changed over time due
to new manufacturing processes. Also, tablet convexity proved challenging for the
colorimeter equipment; sometimes, light reflected off the tablets in a way that made the
results inadequate for analysis (Rodomonte et al., 2010).
Another technique addressed by Wilczyński et al. (2016) was hyperspectral
imaging. A special camera would scan a drug sample in the VNIR (400–1000 nm) and
SWIR (1000–2500 nm) range and measure the reflectivity of the sample. Significant
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differences in reflection were observed when analyzing counterfeit and legitimate
samples of Sildenafil citrate. An advantage of hyperspectral imaging was that it was
non-destructive; consequently, analyzed samples could also be investigated with other
additional analytical techniques. Many samples could be analyzed concurrently, saving
time for investigators. The test was reportedly almost 100% reliable in differentiating
counterfeit and genuine drugs. However, this technique requires sophisticated and
expensive equipment and a good degree of technical knowledge on behalf of the operator
(Wilczyński et al., 2016).

High Performance Liquid Chromatography
In the 1960s, Professor C. Horvath of Yale University developed the first HPLC
instrument: it utilized small glass beads with a porous surface layer to enhance the
transfer of mass between the surface and liquid phase (Kazakevich & Lobrutto, 2007).
Due to the significant resistance to flow developed by the beads, Professor Horvath
decided to build an instrument that packed these beads into columns and passed a
continuous flow of liquid through them. In 1970, Horvath introduced his new separation
method as “High Performance Liquid Chromatography” (Kazakevich & Lobrutto, 2007).
This type of analysis involves dissolving a specified chemical analyte and
pumping it under high pressure through a column containing many glass, porous beads.
The instrument then measures the UV absorbance of the analyte with respect to the
elution time from the column and reports it to the user through a software program. By
comparing the elution time retrieved experimentally with the elution time of a known
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reference standard, the user can determine whether a sample of drug is legitimate or not
(Chang et al., 2015).
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The HPLC System
Within the typical HPLC system, the main components include solvent reservoirs,
pumps, injector, column, detector, and data acquisition and control system (Kazakevich &
Lobrutto, 2007). A similar HPLC system to the one used in the lab is displayed in Figure
2.

Figure 2: A Shimadzu HPLC System (Shimadzu, 2020)
The pump allows for the constant and continuous flow of the mobile phase
solvent through the system. The injector introduces the analyte mixture into the mobile
phase before it reaches the column. A specialized glass syringe is used to load the analyte
into the injector. Once the system has started running, the analyte is injected, and the
analyte can flow with the mobile phase into the column. The column is the heart of an
HPLC system because it separates the analytes in the mixture. Modern HPLC columns
usually consist of a narrow stainless-steel tube filled with small, rigid, and porous beads
(1-5 μm). Special end-fittings with porous frits allow fluid flow through the column while
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retaining the small beads. The mobile phase is in contact with the stationary phase in the
column, which interfaces with a large surface area (Kazakevich & Lobrutto, 2007).
As the analyte and solvent phases leave the column, UV detection monitors the
UV adsorbance at a specified wavelength or span of wavelengths. When the analyte
appears in the detector, a change of adsorbance is registered. If the analyte absorbs more
UV light than the mobile phase, the detector reads out a positive signal. The readout
chromatogram shows retention over time: as an analyte is eluted from the column, the
detector sends a signal to the computer, which is represented as a peak. A computer with
specialized software acts as the data acquisition and control system. The computer
acquires data from the detector as well as system performance data, like solvent pressure,
runtime, flow rate, etc. (Kazakevich & Lobrutto, 2007).

Solvents
The solvent reservoirs store enough solvent for continuous operation of the
HPLC; they may be as simple as 1-L glass beakers. The solvent used depends on the
analyte. It is critical to consider polarity when selecting solvents. Solvent fronts of
different polarities are used to wash the column and release trapped impurities, readying
it for analytical use. Analyte retention increases as the relative polarity of the stationary
phase increases. Variation of polar modifier in the mobile phase controls analyte
retention, which is measured on the chromatogram readout (Kazakevich & Lobrutto,
2007).
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Buffers
A buffer is a solution that maintains solution pH when a small amount of acid or
base is added (Dolan, 2007). Buffer capacity determines the most effective range of the
buffer to prevent large changes in pH. Typically, this is around +/- 1 pH unit of the
buffer’s pKa. Common acids and bases used to make buffers include phosphoric acid,
formic acid, acetic acid, and dimethylamine (Kazakevich & Lobrutto, 2007). In the case
of Amoxicillin, the buffer solution may contain acetonitrile and water (Lieberman, 2018).
Buffers are necessary for controlling the pH stability of the mobile phase and
preserving column durability. If the mobile phase undergoes a large pH change, the
accuracy of the instrument will be greatly reduced (Dolan, 2007). When exposed to high
pH solutions, the silica within the column will degrade at a faster rate- this may affect the
chromatogram and reduce the service life of the column. It is suggested to run a pH of
greater than 2 but less than 8 to prevent loss of silica due to bonded phase loss (Dolan,
2007).
The preferred method of buffer preparation involves weighing the buffer
components according to the recipe and then diluting them with water to the desired
volume (Dolan, 2007). Although it is more involved and takes more time, it is more
accurate and easier to produce from lab to lab. Checking the pH of the buffer solution
after preparation is a good way to ensure the buffer solution was prepared correctly
(Dolan, 2007). It is key to filter the buffer solution after it has been prepared. Even if the
buffer is chemically pure, it still may contain trace amounts of dust from the surrounding
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environment. It is suggested to filter the buffer through a 0.5 μm porosity filter prior to
use (Dolan, 2007).
In order to keep the analyte at a specified pH, very little buffer is needed. This is
because the amount of analyte mass in the column will be “no more than a few hundred
nanograms” (Dolan, 2007). Because there is only a very small amount of analyte, a
proportionate amount of buffer will be comparatively small.

Methods and Materials
Different analytes require different methods based on their chemical properties.
These methods determine the identity of the HPLC column as well as the solvents used
and their ratios (Kazakevich & Lobrutto, 2007). For testing Amoxicillin samples, the
DPAL methodology manual suggests a 100x4.6 mm C18 column, a sample concentration
of 0.50 mg/mL, a 20 μL injection volume, a flow rate of 1.0 mL/min, and a detector
wavelength of 220 nm. The gradient method provided by the DPAL methodology manual
lasted 12 minutes and can be found in the appendices section (Lieberman, 2018). The
HPLC used was composed of Shimadzu components, including a SPD-10A VP UV-Vis
detector, a CBM-10AW VP communications bus module, two LC-10AT VP liquid
chromatograph pumps, and a DGU-14A degasser module. The column used for this
research was a Kromasil 100x4.6 mm C18 column purchased from Sigma-Aldrich. The
solvents used in the method were HPLC-grade methanol from Sigma-Aldrich, vacuum
filtered with 0.45-micron Teflon filter, and a 20 mM monosodium phosphate buffer at pH
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4.4, prepared from 0.5-micron nylon filter vacuum-filtered Milli-Q distilled H₂O
(Lieberman, 2018).
Vacuum-filtered (0.5-micron nylon filter) Milli-Q distilled H₂O was used for
column wash methods and for automatic pump rinsing. The 20 mM monosodium
phosphate buffer of pH 4.4 was made with vacuum-filtered Milli-Q H₂O (0.5-micron
nylon filter). The dissolved solute was 2.7598 g of Fisher Scientific sodium phosphate
monobasic, massed with an Ohaus GA200D balance. HPLC-grade H₂O (700 mL) was
added to a 1000-mL beaker. Using a Corning PC-420 stirrer/hot plate, the water was
stirred and heated to 30 ℃ to aid in dissolution of the solid monosodium phosphate.
Then, monosodium phosphate was added to the water and stirred with a magnetic stirrer
until completely dissolved. Using a calibrated Accumet AB150 pH meter, the pH of the
solution was adjusted dropwise with 1 M solution HCl and NaOH until pH 4.4 was
reached. Finally, the solution volume was brought up to 1000-mL with HPLC-grade H₂O.
The solution was let to cool to room temperature, 20 ℃, before adjusting the pH. The
standard amoxicillin was purchased from Sigma-Aldrich. In order to dilute standard
solutions, 2.0 mg of amoxicillin standard was massed with an Ohaus GA200D balance,
then added to a 2-mL glass vial. HPLC-grade H₂O (2.0 mL) was added to the vial, then
the sealed vial was heated with lukewarm tap water and centrifuged to aid in dissolution.
Once the solute was fully dissolved, a set of six 1:2 ratio serial dilutions were set up with
2-mL glass vials. This yielded solutions of 1.0 mg/mL, 0.5 mg/mL, 0.25 mg/mL, 0.125
mg/mL, 0.0625 mg/mL, and 0.03125 mg/mL. Each of these solutions was filtered with a
0.2-μm Pall Acrodisc syringe filter and then returned to a new labelled vial. Each
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standard solution was analyzed three times, creating eighteen total chromatograms. The
area of the peak of each chromatogram was collected, then plotted on a scatter plot with
concentration being the independent variable and peak area being the dependent variable.
A linear trendline was created in Excel, then used to calculate the theoretical
concentration of samples suspected to be illegitimate samples of amoxicillin.
Suspect samples were provided by the University of Notre Dame DPAL. On the
packaging of the samples, it was noted that they were marked as intended to be sold on
the Kenyan market. In Figure 3, sample 19k3 is pictured in its original packaging.
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In order to dilute suspect samples, a similar method for standard dilution was
used. The sample capsules were opened, photographed, and then 1.0 mg of sample was
massed with an Ohaus GA200D balance.
This was added to a 2-mL vial, then 2 mL of HPLC grade H₂O was added to
dissolve the sample. Then the sealed vial was heated with lukewarm tap water and
centrifuged to aid in dissolution. The solution was filtered with a 0.2-μm Pall Acrodisc
syringe filter and then returned to a new labelled vial. A 20 μL volume of solution was
injected with a Hamilton 50-μL HPLC injection syringe for every sample or standard
analysis.

Figure 3: Sample 19k3
Testing of Samples
Analyzing the chromatogram of a sample and then comparing that with a standard
is a reliable way to determine whether a sample is legitimate or not. The peak of the
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sample and the standard should occur at around the same retention time. There should be
the same number of peaks in both the sample and the standard. If the sample had more
peaks, this may indicate the presence of contaminants or degradation products
(Lieberman, 2018). Peak area should also be comparable between standards and samples
of the same theoretical concentration. If the peak area of a sample was very low
compared to a standard, this would indicate that the drug manufacturer is adding less than
the advertised amount of drug to each capsule.
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Results and Discussion
By interpreting several characteristics of the chromatogram, including the
retention time, peak area, and shape of peak, it is possible to determine whether, with a
reasonable degree of confidence if a sample is legitimate. The results can be interpreted
by comparing the chromatograms of the samples and standards for similarity. The
samples should have a retention time like the standard: if not, this indicates the presence
of a chemical with a different polarity and may indicate a counterfeit drug (Bellur Atici et
al., 2017). Drug counterfeiters may add additional chemicals to a drug to give the false
impression that their drugs have the proper concentration and legitimacy (Kelesidis et al.
(2015). A chromatogram of such a counterfeit may have a different number of peaks than
expected from a standard solution. If peak areas aren’t consistent between standard and
sample, this may indicate that the sample may have a lower or higher than expected
concentration. By calculating the concentration of the sample with the equation derived
from the standard curve, it is possible to estimate the concentration of samples.
Counterfeit drug makers may try to cut costs by lowering the concentration of active
ingredient, and then claiming the drug contains the full advertised concentration (Jarrells,
2015). Therefore, a sample that shows a lower concentration may indicate a counterfeit
drug. If a sample was suspected to be counterfeit, further testing would be required before
reporting results to the DPAL (Lieberman, 2018)
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Chromatograms
In Figure 4, a chromatogram of a standard amoxicillin solution shows a retention
time of 3.325 minutes. From the 6 to 11-minute region, additional substances leave the
column giving several smaller peaks: these peaks were not integrated in the results. As
seen in the Appendix section 3: Area Reports of Samples (page 42), experimental results
on tested samples show similar results.

Figure 4: Chromatogram of Standard Solution, Concentration: 0.5 mg/mL
Compared to a standard sample of amoxicillin, as seen in Figure 4, there are a few
differences. The retention time of the standard was longer at an average 3.342 minutes,
compared to a suspect sample like 19k2 with an average retention time of 3.151 minutes.
This may be due to variation caused by the lack of a column oven. Temperature changes
over time may affect the chromatogram (Kazakevich & Lobrutto, 2007). The peak
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characteristics are similar in appearance, with a large, narrow peak at approximately 3
minutes.

Standard Curve
A standard curve for amoxicillin was generated by making six separate serial
dilutions from a stock solution of 1.0 mg/mL at a dilution factor of two. After
chromatograms were generated for each analysis, the area under the largest peak was
calculated, then plotted in a scatter plot with concentration (mg/mL) as the independent
variable and peak area as the dependent variable. The scatter plot is presented in Figure 5,
with an approximately linear pattern with an R² value of 0.997.

Figure 5: Concentration (mg/mL) vs. Average Area of Peak, y=2E+07x + 590317,
R² = 0.997
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Analysis of Samples
There were five samples of amoxicillin, labelled 19k1 through 19k5, that were
analyzed. With five separate analyses, sample 19k1 was estimated to have a
concentration of 0.602 mg/mL, with a standard deviation of 0.03. The sample had an
average retention time of 3.147 minutes with a standard deviation of 0.05. Sample 19K2
was estimated to have a concentration 0.543 mg/mL with a standard deviation of 0.01
derived from eight separate analyses of sample 19k2. The sample had an average
retention time of 3.151 minutes with a standard deviation of 0.036. Sample 19k3 had an
average calculated concentration of 0.683 mg/mL, with a standard deviation of 0.03
derived from five analyses. The average sample retention time was 3.113 minutes with a
standard deviation of 0.074. Sample 19k4 had an average calculated concentration of
0.474 mg/mL, with a standard deviation of 0.009 derived from five analyses. The average
sample retention time was 3.060 minutes with a standard deviation of 0.019. Sample
19k5 had an average calculated concentration of 0.620 mg/mL, with a standard deviation
of 0.011 derived from five analyses. The average sample retention time was 3.028
minutes with a standard deviation of 0.022. Table 2 shows the calculated average
concentration and retention time of samples.
Table 1: Average Calculated Concentration and Average Retention Time of Samples
Sample

Calculated Average Concentration ±
Standard Deviation (mg/mL)

Average Retention Time ±
Standard Deviation

19k1

0.6019±0.03

3.147±0.05

19k2

0.5426±0.01

3.151±0.04
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19k3

0.6828±0.03

3.113±0.07

19k4

0.4743±0.01

3.06±0.02

19k5

0.6204±0.01

3.028±0.02
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There appeared to be an excess of amoxicillin in the samples 19k1, 19k2, 19k3,
and 19k5. This may be due to undissolved amoxicillin in the standard solution, or
degradation of the standard solution over time in storage. A degraded standard solution
would give the impression of a higher theoretical concentration in a more recent sample
(Kazakevich & Lobrutto, 2007, Weber & Rubin, 1984). It is also possible that the suspect
samples may contain a higher than advertised concentration of active drug, but that seems
unlikely due to the fact this would cost drug makers more money. Poor quality control,
such as adding too little or too much drug to each capsule, could account for the
higher-than-average concentration (Jarrells, 2015). However, sample 19k2 was one
sample that had a lower than advertised concentration; this may have been due to sample
solution degradation or lack of quality control (Jarrells, 2015). Although there were some
discrepancies between the samples and the standard solution, reporting any samples to
the DPAL was deemed unnecessary (Lieberman, 2018). This was because there were no
additional peaks in the chromatograms of the samples, the retention time of the samples
and standards were similar, and the peak areas of the standards and samples were
comparable.
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Conclusion
Summary of findings
Counterfeit drugs are an emerging threat to public health; globally, it is estimated
that 100,000 people have died from ingesting fake drugs (Blackstone et al., 2014). These
counterfeits are much more prevalent in the developing world, such as sub-Saharan
Africa, compared to a developed region such as Western Europe (WHO, 2010).
Amoxicillin, a commonly prescribed antibiotic, is commonly counterfeited as
well (Kelesidis & Falagas, 2015). Drug samples were retrieved from West African
markets, and then handed over to Dr. Corina Brown for analysis with HPLC. Reference
standard samples purchased from Sigma were used to establish a standard retention time
and to construct a calibration curve. The calibration curve was then used as a reference
standard when investigating the quantity of drug in suspect samples. Quantitatively, the
chromatogram of a possible fake sample will vary in terms of the peak height and number
of peaks. Qualitatively, the sample may appear differently in its packaging or physical
appearance, as well as having a different retention time compared to a reference standard.
Thus, by analyzing drug samples with HPLC and comparing with the reference standards,
we can determine whether samples are legitimate or not.
Sample 19k1, Sample 19k2, Sample 19k3, and Sample 19k5 had a
higher-than-expected calculated concentration. The one exception was Sample 19k4,
which had a lower-than-expected average calculated concentration. All samples had a
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somewhat shorter retention time on average, approximately 3.1 vs 3.3 minutes, compared
to a reference standard.
In all provided samples, our results indicate that every sample is legitimate. The
calculated concentration of drug may have been higher or lower than expected due to a
couple of possible factors, such as differences in the purity of the standard and sample or
sample storage conditions (Lieberman, 2018).

Future Directions and Personal Reflection
From this research I learned how to operate the HPLC instrument, how to write a
scientific paper and thesis, and statistical analysis. The entire project took some patience,
but the results were rewarding in the end. I presented my research at the American
Chemical Society 2021 Regional Conference in Tucson, Arizona and the OUR Fall
Symposium in poster form. I also received research grants from Tri-Beta Biological
Honors Society, Office of Undergraduate Research (OUR), and the NHS College at UNC.
In the future, I plan on taking the skills I learned from this research and applying them to
my future research in my career or further education.
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Appendices
Appendix 1: Gradient method for HPLC analysis of amoxicillin
HPLC Gradient Method for Amoxicillin, Provided by DPAL
Column: Kromasil 100 x 4.6 mm C18 column
Column Temperature: Room temperature
Sample Concentration: 0.5 mg/mL
Amoxicillin Sample Solvent: HPLC grade Water
Mobile Phase A: 100% HPLC Methanol
Mobile Phase B: 20 mM monosodium phosphate buffer, pH 4.4
Flow Rate: 1.0 mL/min
Sample Injection Volume: 20 µL
Table 2: Gradient Description used in HPLC analysis
Time (min)

Mobile Phase A (%)

Mobile Phase B (%)

0

5

95

0.5

5

95

5

30

70

7

90

10

8

90

10

8.5

25

75

10

10

90

11

5

95

12

5

95
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Appendix 2: Area under peak, Calculated Concentration and Retention Time of
samples
Table 3: Sample 19k1
Areas under peak
14292369
14196807
13172833
13202089
13348003
Average
Standard Deviation

Calculated
Concentration (mg/mL)
0.6228
0.6185
0.5719
0.5733
0.5799
0.6019
0.03

Retention time (min)
3.225
3.117
3.142
3.133
3.117
3.147
0.05

Areas under peak

Calculated Concentration
(mg/mL)

Retention time (min)

12204330

0.5279

3.175

12731778

0.5519

3.208

12529437

0.5427

3.183

12644322

0.5479

3.158

12595378

0.5457

3.108

12636699

0.5476

3.142

12815342

0.5557

3.117

12063644

0.5215

3.117

Average:

0.5426

3.151

Standard Deviation:

0.01

0.04

Table 4: Sample 19k2
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Table 5: Sample 19k3
Areas under peak

Calculated Concentration
(mg/mL)

Retention time (min)

16543145

0.7251

3.058

14950237

0.6527

3.233

14999719

0.6550

3.083

15859171

0.6940

3.133

15706483

0.6871

3.058

Average

0.6828

3.113

Standard Deviation

0.03

0.07

Calculated Concentration
(mg/mL)

Retention time (min)

11073268

0.4765

3.083

10772215

0.4628

3.042

11119942

0.4786

3.042

10880466

0.4677

3.075

11274238

0.4856

3.058

Average:

0.4743

3.060

Standard Deviation:

0.01

0.02

Table 6: Sample 19k4
Area under peak
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Table 7: Sample 19k5
Areas under peak

Calculated Concentration
(mg/mL)

Retention time (min)

13931265

0.6064

3.025

14227105

0.6199

3.050

14612736

0.6374

3.050

14128564

0.6154

3.000

14291675

0.6228

3.017

Average:

0.6204

3.028

Standard Deviation:

0.01

0.02
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Appendix 3: Area Reports of Samples

Figure 6: Sample 19k1 Chromatogram

Figure 7: Sample 19k2 Chromatogram

48

Figure 8: Sample 19k3 Chromatogram

Figure 9: Sample 19k4 Chromatogram
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Figure 10: Sample 19k5 Chromatogram
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